Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Wulandari Bangun Laksana Tbk (BSBK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Wulandari Bangun Laksana TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Wulandari Bangun Laksana Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Wulandari Bangun Laksana Tbk trades at Rp53 (market cap 1.35T, 281.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B). The key difference: Wulandari Bangun Laksana Tbk is far larger — about 8.2× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.

BSBKOBAT
Market Cap
1.35T164.65B
Volume
281.8K
Lot
2.82K
Turnover
14.94M
Average Price
53.01
Value
14.94M
Indicative Equilibrium Price
54238
Indicative Equilibrium Volume
2.6K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSBK
View details
OBAT
View details

About Wulandari Bangun Laksana Tbk

PT Wulandari Bangun Laksana Tbk (the “Company”) was established under the name PT Dwipagrya Lestari in Jakarta based on Deed No. 21 dated September 7, 1994 by Linda Ibrahim, S.H., Notary in Jakarta. The Company commended its commercial operations on 2005.

Read more on BSBK

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT